Product Information

CYCLOSPORINE MODIFIED 25 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3174 per EA under NDC 00093901865. Its NADAC has been published 265 times since Jul 28, 2021.

FDA first approved this application on Mar 29, 2005. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CYCLOSPORINE MODIFIED 25 MG

Cyclosporine
$0.3174per EA

Strength

25 mg/1

NDC

00093901865

Classification

Generic

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CYCLOSPORINE

Approval Type

Generic (ANDA)

FDA Application

ANDA065110

FDA Approved

3/29/2005

TE Code

AB1

On Market Since

6/8/2021

Pharmacological Classes

Calcineurin Inhibitor Immunosuppressant
Calcineurin Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for CYCLOSPORINE MODIFIED 25 MG has been published 265 times since Jul 28, 2021, and over the history we have for it it has declined 48.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3174 per EA
All-time high$0.6559 (Sep 15, 2021)
All-time low$0.3100 (Apr 22, 2026)
52-week high$0.3448
52-week low$0.3100
Median price$0.4533
Average price$0.4480
Largest weekly change+53.8% (Aug 21, 2024)
Weeks tracked265
Tracking sinceJul 28, 2021

Price History

1W

-1.1%

1M

-1.1%

3M

+1.1%

6M

-0.3%

1Y

-8.0%

3Y

-33.3%

5Y

-51.6%

All

-48.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CYCLOSPORINE MODIFIED 25 MG?

The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE MODIFIED 25 MG, manufactured by Teva Pharmaceuticals USA Inc., is $0.3174 per EA (NDC 00093901865), effective Aug 19, 2026.

How has the price of CYCLOSPORINE MODIFIED 25 MG changed over time?

Over the history we have for it, the NADAC for CYCLOSPORINE MODIFIED 25 MG has declined 48.6%. It has been tracked across 265 weekly CMS publications since Jul 28, 2021.

What are the highest and lowest recorded NADAC prices for CYCLOSPORINE MODIFIED 25 MG?

Since Jul 28, 2021, the NADAC for CYCLOSPORINE MODIFIED 25 MG has ranged from a low of $0.3100 (Apr 22, 2026) to a high of $0.6559 (Sep 15, 2021), with a median of $0.4533 per EA.

Are there cheaper alternatives to CYCLOSPORINE MODIFIED 25 MG?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOSPORINE MODIFIED 25 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures CYCLOSPORINE MODIFIED 25 MG?

CYCLOSPORINE MODIFIED 25 MG (NDC 00093901865) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.